Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7
Published October 26, 2022 · Recall initiated: September 30, 2022
Summary
FDA records drug Class II recall D-0010-2023, published October 26, 2022 and initiated September 30, 2022. Recalling firm: Ingenus Pharmaceuticals Llc; Status: Completed; Reported quantity: 6176 bottles; Lot: Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Out of specification for related substances (impurities).
What to do
Voluntary: Firm initiated · Letter
Get an email if FLUNISOLIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FLUNISOLIDE
- Manufacturer
- Ingenus Pharmaceuticals Llc
- Distributor
- Nationwide within the United States
- UPC
- 350742317257
- Lot
- Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDARifampin Capsules, USP, 300 mg, packaged in a) 30-count bottle (NDC 51407-323-30), b) 60-count bottle (NDCOctober 26, 2022
- FDARifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Manufactured by Patheon Pharmaceuticals Inc., OH,October 26, 2022
- FDAAcyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx only, Distributed by: AuroMedicsOctober 26, 2022
- FDAPrismaflex HF20 Set (product code 109841). For use in providing continuous fluid management and renalOctober 19, 2022
- FDAHobbs Medical Polypectomy Snare Catalog Number: 4575-OLYOctober 19, 2022
- FDAHobbs Medical Polypectomy Snare Catalog Number: 4565-OLYOctober 19, 2022
Questions about this recall
Was Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7 recalled?
Yes. FDA published recall D-0010-2023 on October 26, 2022. Reported hazard: Out of specification for related substances (impurities).
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FLUNISOLIDE. UPC: 350742317257.